Medical need, scientific opportunity and the drive for antimalarial drugs.
about
The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparumModeling the effects of integrating larval habitat source reduction and insecticide treated nets for malaria controlIdentification of an antimalarial synthetic trioxolane drug development candidateGenome sequence of the human malaria parasite Plasmodium falciparumThe unusually large Plasmodium telomerase reverse-transcriptase localizes in a discrete compartment associated with the nucleolusExpression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarrayGenomics research and malaria control: great expectationsConstruction and use of Plasmodium falciparum phage display libraries to identify host parasite interactionsSynthesis and stereochemical determination of an antiparasitic pseudo-aminal type monoterpene indole alkaloidThe counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidenceMalaria Control with Transgenic MosquitoesFunctional analysis of protein kinase CK2 of the human malaria parasite Plasmodium falciparumIdentification and initial characterization of three novel cyclin-related proteins of the human malaria parasite Plasmodium falciparumCharacterization of a UBC13 kinase in Plasmodium falciparumCopper Homeostasis for the Developmental Progression of Intraerythrocytic Malarial ParasiteEndoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffoldA murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytesUtilizing a dynamical description of IspH to aid in the development of novel antimicrobial drugsDiscovery of New Compounds Active against Plasmodium falciparum by High Throughput Screening of Microbial Natural ProductsOptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimensChemical genetics of Plasmodium falciparumComparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan familyPlasmodium falciparum regulatory subunit of cAMP-dependent PKA and anion channel conductancePotent, Plasmodium-selective farnesyltransferase inhibitors that arrest the growth of malaria parasites: structure-activity relationships of ethylenediamine-analogue scaffolds and homology model validation.Integration and mining of malaria molecular, functional and pharmacological data: how far are we from a chemogenomic knowledge space?Parallel synthesis of 9-aminoacridines and their evaluation against chloroquine-resistant Plasmodium falciparumResonance Raman spectroscopy in malaria research.Novel 4-aminoquinoline-pyrimidine based hybrids with improved in vitro and in vivo antimalarial activity.Deciphering the late biosynthetic steps of antimalarial compound FR-900098.Exploring the role of socioeconomic factors in the development and spread of anti-malarial drug resistance: a qualitative study.Monitoring the uptake of glycosphingolipids in Plasmodium falciparum-infected erythrocytes using both fluorescence microscopy and capillary electrophoresis with laser-induced fluorescence detection.Perturbation of copper homeostasis is instrumental in early developmental arrest of intraerythrocytic Plasmodium falciparum.A complement receptor-1 polymorphism with high frequency in malaria endemic regions of Asia but not Africa.In vitro and in vivo anti-malarial activity of Boerhavia elegans and Solanum surattense.Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3.The antimalarial drug artemisinin alkylates heme in infected mice.Ruthenium(II) arene complexes with chelating chloroquine analogue ligands: synthesis, characterization and in vitro antimalarial activity.Use of Broken-Symmetry Density Functional Theory To Characterize the IspH Oxidized State: Implications for IspH Mechanism and Inhibition.Chemotherapeutic hope on the horizon for Plasmodium vivax malaria?Recent progress in the development of anti-malarial quinolones.
P2860
Q21128645-537333F1-335D-49DE-A1D5-54ADFAEF8F72Q21142765-229EDF33-EB76-4E50-B877-AC6F27AD4BDAQ22061876-7B32ECCB-D8BA-495A-B1C6-7AA4CAC0003EQ22122524-FD29FDBB-4129-43F6-8770-377699DB2D4DQ24791591-F4A8BDD7-74AD-4568-A9D7-9AABF739F1F3Q24804829-F67870D5-6722-4594-AC2F-ECD94EB550E8Q24806742-DE3CDA0E-EF59-4F67-A2EE-458635B5B7E3Q24807148-3B6E3092-BC1F-4A2F-AAC2-602BB0D213BEQ26744255-0BF1086C-EFA9-4309-B856-2FE25BA2CF69Q26828002-0100E952-3C1E-43A9-9F8B-19B793FADBAFQ27487877-8D9E0914-B9B2-42D6-9FF7-636CB5A2B52DQ27973597-8D456DDE-B5A9-4F6A-8DCA-A8367C1CB77CQ27974723-A23A89A3-3653-4140-8847-BFAD59B7BFCCQ27976461-32A4F0A8-5A83-44C5-AB5C-DD6B290249F5Q28067773-C25E7C2A-AE2E-494D-87CB-5A23EB3368A4Q28077102-117F9D03-2D77-45F0-B880-C1D36DDC15E6Q28472751-A5239AA5-0778-49BA-B528-D56FFAFBC884Q28537776-EAE442B2-C27D-4B7F-BAD5-5D47D7962A9EQ28552116-5AFEA7A3-5B10-4DF5-9982-3A6EC34FB93EQ28831110-F60FAD46-BD06-4ECE-A09A-C8367AE90A75Q29617272-B4F3686C-3B67-4BAC-ADCC-6C2FBDAD1128Q30039212-7CB2CF44-AB36-4A6A-BCBE-192AD8BE33A0Q30042466-CC05909A-D21E-47EC-93A2-9D653F8E8AECQ30498356-D6877126-F089-4F2C-813A-6DE95941FF53Q31078360-7C5726BB-153A-4284-B0D2-3955E4DA276DQ33224951-6B6CA924-567A-4898-B817-2B2CC1621AA1Q33262368-47100C27-4D8A-4A78-A91F-91BC853664C3Q33630451-730A19A2-05BF-4DB6-BD3F-69F470BD034FQ33645098-141DB90A-74DB-4D6A-A073-482242106E1FQ33706538-0DE58FED-9273-4F96-A5F4-29F35ACEDF47Q33736199-991BA579-81D7-48E2-A1B2-CCB755ACF9B7Q33842017-3EDF59B5-C5EB-4FCD-A6F5-BB0887608945Q33881742-3A43C1C6-1977-45D3-84F2-F1C8D9EE2E40Q33895134-1E6CB188-F4D1-40E5-ADDA-89DE42647248Q33935408-8D2016DA-5DBF-41C0-BA02-0DBB658537EFQ34015782-9F277F28-CDDF-42D7-AC67-0157E5460A5CQ34128946-6B5605D6-EF1A-4D80-B59B-E21AF519B639Q34155674-38D9F117-C66A-4B31-9526-6F7657AB70CFQ34159239-111BF5CE-B98A-4B7E-B67E-33C5C265F753Q34174639-FF342453-74CE-489B-8130-FDE108D287AF
P2860
Medical need, scientific opportunity and the drive for antimalarial drugs.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Medical need, scientific opportunity and the drive for antimalarial drugs.
@ast
Medical need, scientific opportunity and the drive for antimalarial drugs.
@en
Medical need, scientific opportunity and the drive for antimalarial drugs.
@nl
type
label
Medical need, scientific opportunity and the drive for antimalarial drugs.
@ast
Medical need, scientific opportunity and the drive for antimalarial drugs.
@en
Medical need, scientific opportunity and the drive for antimalarial drugs.
@nl
prefLabel
Medical need, scientific opportunity and the drive for antimalarial drugs.
@ast
Medical need, scientific opportunity and the drive for antimalarial drugs.
@en
Medical need, scientific opportunity and the drive for antimalarial drugs.
@nl
P356
P1433
P1476
Medical need, scientific opportunity and the drive for antimalarial drugs.
@en
P2093
Robert G Ridley
P2888
P304
P356
10.1038/415686A
P407
P577
2002-02-01T00:00:00Z
P5875
P6179
1049965895